Jaguar Health (JAGX) EPS (Weighted Average and Diluted) Growth (3y) (2020 - 2026)
Jaguar Health (JAGX) EPS (Weighted Average and Diluted) Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
41.33% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
-78.53% |
| Date | Value |
|---|
| Mar 31, 2026 |
-78.53% |
| Dec 31, 2025 |
-41.25% |
| Sep 30, 2025 |
10.74% |
| Jun 30, 2025 |
-5.37% |
| Mar 31, 2025 |
-193.57% |
| Dec 31, 2024 |
30.63% |
| Sep 30, 2024 |
-360.05% |
| Jun 30, 2024 |
-104.73% |
| Mar 31, 2024 |
-577.62% |
| Dec 31, 2023 |
-2,946.94% |
| Sep 30, 2023 |
-231.08% |
| Jun 30, 2023 |
-354.65% |
| Sep 30, 2021 |
19.10% |
| Sep 30, 2020 |
-36.77% |
